InterVenn Biosciences
INDUSTRY newsLife Science
Elon Musk’s Neuralink Fills 144,209 SQFT Void in South San Francisco
The timing couldn’t be more countercyclical. As life sciences landlords hemorrhage tenants across the Peninsula, Elon Musk’s neurotechnology startup is moving in. When...
FinanceINDUSTRY newsLife Science
Lonza Group Pulls Out of Lease Negotiations for 150,000 SQFT of Life Science Space in Emeryville
By Kate Snyder A global biotech company based in Switzerland that was in talks to lease space at the Atrium in Emeryville has...
INDUSTRY newsLife Science
A Year After Signing a Decade-Long Lease, InterVenn Pulls Out of 144,000 SQFT Building in South San Francisco
By Vladimir Bosanac A year after it announced a major expansion and signed a 10-year lease, the six-year-old InterVenn Biosciences is pulling out...
AECCommercialFinanceINDUSTRY newsLife Science
InterVenn Biosciences Signs Lease for 142,000 SQFT in South San Francisco
By Catherine Sweeney InterVenn Biosciences is expanding its reach across South San Francisco. The company, which focuses its work on glycoprotein analysis, has...
